BTC
NVO

Bank & Trust Company’s Novo Nordisk NVO Stock Holding History

Bank & Trust Company’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2K Hold
233
– – 0.01% 240
2026
Q1 		$8.56K Hold
233
– – 0.01% 245
2025
Q4 		$11.9K Sell
233
-24
-9% -$1.23K 0.01% 228
2025
Q3 		$14.3K Hold
257
– – 0.01% 212
2025
Q2 		$17.7K Hold
257
– – 0.01% 199
2025
Q1 		$17.8K Buy
257
+96
+60% +$7.93K 0.01% 195
2024
Q4 		$13.8K Buy
161
+93
+137% +$10.1K 0.01% 207
2024
Q3 		$8.1K Hold
68
– – 0.01% 230
2024
Q2 		$9.71K Buy
+68
New +$9.01K 0.01% 225

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bank & Trust Company's NVO Position: Q2 2026 in Review

Bank & Trust Company held its Novo Nordisk (NVO) position steady in Q2 2026 at 233 shares worth $11.2K. The position accounts for 0.01% of the portfolio, ranked #240.

Bank & Trust Company first reported a position in NVO in Q2 2024 and has held it in 9 quarters since. The position peaked at $17.8K in Q1 2025. 580 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Bank & Trust Company held 233 shares of Novo Nordisk worth $11.2K as of Q2 2026.
  • Bank & Trust Company left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.01% of Bank & Trust Company's portfolio in Q2 2026, its #240 holding.
  • Bank & Trust Company first reported a position in Novo Nordisk in Q2 2024 and has held it in 9 quarters since.
  • Bank & Trust Company's Novo Nordisk position peaked at $17.8K in Q1 2025.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Bank & Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.